~~<i id='383996A976'><strike id='383996A976'><tt id='383996A976'><pre id='383996A976'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

knowledge

author：focus 2025-10-02 22:57:48 - browse：9374

Pharmacy shelves — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter. GEORGE FREY/AFP via Getty Images

WASHINGTON — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter — its highest-ever spend by far, according to federal filings.

The Council for Citizens Against Government Waste spent $1.1 million on lobbying last quarter, and only employed a single lobbyist. That’s 22 times the $50,000 it spent in the same quarter last year. Its prior spending record was $700,000, from the start of 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： In utero gene editing: an explainer

hotspot

knowledge

hotspot

explore

leisure time

explore

AdobeApanelofgovernmentadvisersfinallyhasendorsedideasforCongresstosolvetheparticularlythornyproblem

WSS

Why palliative psychiatry is worth discussing

Diversify hospital leadership teams to protect BIPOC patient health

Victims of gun violence feel impacts long after bullet wound

Alabama hospital puts IVF treatments on hold

HPV cancer vaccine study demonstrates efficacy

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

focus

knowledge

hotspot

New air purifier tech could be key to improving indoor air quality

Removing probiotics from the NICU could threaten preemies' health

How to save PrEP access — and even expand it

A new nitrogen execution bill also undermines medical licensing

Apple is now the first public company to be valued at $3 trillion

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Medicare details structure of new drug price negotiation program

Why palliative psychiatry is worth discussing

Walensky prepares to leave CDC — and Congress — behind

R1 RCM gets $5.8 billion buyout offer from private equity firm

knowledge

HPV cancer vaccine study demonstrates efficacy

The Sacklers, horror, and ‘The Fall of the House of Usher’

PBM reform efforts get punted in Congress

R1 RCM gets $5.8 billion buyout offer from private equity firm

Alabama IVF ruling threatens families facing fatal genetic disease

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

hotspot

explore

leisure time

explore